Advertisement

Author: Jakob Emerson

The nation's largest payers saw generally stable financial results in the first quarter of 2023 despite economic uncertainty throughout the broader healthcare industry, according to a June 6 analysis from Fitch Ratings shared with Becker's.

Advertisement

Individuals who are prescribed GLP-1 or SGLT-2 drugs for diabetes and who have a low copay are more likely to take those drugs for more than one year compared to those with high copays, according to a study published June…

Advertisement